Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Endocrine 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 37Lung Neoplasms 21Brain Neoplasms 21Prostatic Neoplasms 20Pancreatic Neoplasms 20Neoplasm Metastasis 20Carcinoma, Hepatocellular 17Melanoma 15Breast Neoplasms 12Squamous Cell Carcinoma of Head and Neck 8Carcinoma, Renal Cell 8Neoplasms 7Small Cell Lung Carcinoma 6Liver Neoplasms 6Glioblastoma 6Sarcoma 5Head and Neck Neoplasms 4Salivary Gland Neoplasms 3Recurrence 3Kidney Neoplasms 3Gliosarcoma 3Glioma 3Colorectal Neoplasms 3Colonic Neoplasms 3Cholangiocarcinoma 3Adenocarcinoma of Lung 3Uveal Melanoma 2Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Sarcoma, Ewing 2

Interventions

mirdametinib 2tipifarnib 1peginterferon alfa-2b 1nilotinib 1binimetinib 1Vincristine 1Temozolomide 1Radiosurgery 1Imatinib Mesylate 1Everolimus 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Neurofibroma × Radiosurgery × Clear all
NCT01347307 2020-06-18

Stereotactic Body Radiotherapy for Spine Tumors

Mercy Research

Phase NA Completed
38 enrolled 11 charts
CNSEndocrineSarcoma

Arteriovenous Malformations, Chordoma, Meningioma, Neurilemmoma, Neurofibroma, Paraganglioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡